A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE)
Publication Date
6-1-2024
Presented At:
American Society of Clinical Oncology (ASCO) Annual Meeting
Citation
Ahluwalia, Manmeet; Odia, Yazmin; and Ozair, Ahmad, "A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE)" (2024). All Publications. 5481.
https://scholarlycommons.baptisthealth.net/se-all-publications/5481